| 发明名称 |
4-(2-BUTYLAMINO)-2,7-DIMETHYL-8-(2-METHYL-6-METHOXYPYRID-3-YL) PYRAZOLO-[1,5-A]-1,3, 5-TRIAZINE, ITS ENANTIOMERS AND PHARMACEUTICALLY ACCEPTABLE SALTS AS CORTICOTROPIN RELEASING FACTOR RECEPTOR LIGANDS. |
| 摘要 |
<p>Corticotropin releasing factor (CRF) antagonists of Formula (I): and its use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.</p> |
| 申请公布号 |
MXPA03008185(A) |
申请公布日期 |
2004.01.29 |
| 申请号 |
MX2003PA08185 |
申请日期 |
2002.03.06 |
| 申请人 |
BRISTOL-MYERS SQUIBB PHARMA COMPANY |
发明人 |
PAUL J. GILLIGAN |
| 分类号 |
G01N33/50;A61K31/53;A61P1/04;A61P1/14;A61P3/04;A61P3/08;A61P9/00;A61P15/00;A61P15/08;A61P21/00;A61P25/00;A61P25/06;A61P25/08;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P29/00;A61P31/18;A61P37/06;A61P43/00;C07D403/00;C07D487/04;G01N33/15;G01N33/53;G01N33/566;(IPC1-7):A61K31/53 |
主分类号 |
G01N33/50 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
